SWOT Analysis for Mineralys Therapeutics Inc

Relative Strength Index (RSI) Bullish
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over Half Year (6 Months)
Relative Outperformance versus Industry over the Quarter (3 Months)
Stocks whose current price is 20% higher than week low, and more than previous close
PEG lower than Industry PEG
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Stock gained more than 20% in one month
Top Gainers
Stock with Low PE (PE < = 10)
Stocks near 52 Week High with Significant Volumes
Volume Shockers
High Volume, High Gain
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years